Cadila Healthcare receives Investment Bank Analyst Rating Update
- Investing.com
Pro- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Zydus Lifesciences Ltd (ZYDU)Zydus Lifesciences Ltd stock price live, this page displays NS ZYDU stock exchange data. View the ZYDU premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Zydus Lifesciences Ltd real time stock price chart below.
What Is the Zydus Lifesciences Ltd Stock Price Today?
The Zydus Lifesciences Ltd stock price today is 978.35.
What Is the Stock Symbol for Zydus Lifesciences Ltd?
The stock symbol for Zydus Lifesciences Ltd is "ZYDU."
What Stock Exchange Does Zydus Lifesciences Ltd Trade On?
Zydus Lifesciences Ltd is listed and trades on the NSE stock exchange.
Is Zydus Lifesciences Ltd a Good Stock to Buy?
Determining whether Zydus Lifesciences Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ZYDU quote. (ISIN: INE010B01027)
What Is the Zydus Lifesciences Ltd Stock Price Today?
The Zydus Lifesciences Ltd stock price today is 978.35.
What Is the Stock Symbol for Zydus Lifesciences Ltd?
The stock symbol for Zydus Lifesciences Ltd is "ZYDU."
What Stock Exchange Does Zydus Lifesciences Ltd Trade On?
Zydus Lifesciences Ltd is listed and trades on the NSE stock exchange.
Is Zydus Lifesciences Ltd a Good Stock to Buy?
Determining whether Zydus Lifesciences Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ZYDU quote. (ISIN: INE010B01027)
978.35
+2.70(+0.28%)
Closed
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
955.40
990.00
52 wk Range
642.45
1,323.90
ZYDU Scorecard
Full Analysis
Trading at a low P/E ratio relative to near-term earnings growth
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
955.40990.00
52 wk Range
642.451,323.90
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.31%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.31%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
ZYDU Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Neutral
Analysts Sentiment
Neutral
Price Target
1,083.36
Upside
+10.72%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock generally trades with low price volatility
- Cadila Healthcare receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Cadila Healthcare receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Cadila Healthcare receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Cadila Healthcare receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Cadila Healthcare receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Cadila Healthcare receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Cadila Healthcare receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Cadila Healthcare receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Cadila Healthcare receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Zydus Lifesciences Ltd Company Profile
Zydus Lifesciences Limited engages in the research, development, production, marketing, distribution, and sale of pharmaceutical products in India, the United States, and internationally. It operates through two segments: Pharmaceuticals and Consumer Products. It offers finished dosage human formulations, such as generics; branded generics; specialty formulations, including biosimilars and vaccines; active pharmaceutical ingredients; consumer wellness products; animal healthcare products; and products in the therapeutic areas of pain management, neurology, metabolic disorder, and liver diseases. The company provides the products under the Everyuth, Nutralite, SugarFree, Complan, Glucon-D, and Nycil brands. In addition, the company offers a pipeline of biological products in the areas of oncology, autoimmune disease, nephrology, inflammation, rheumatology, hepatology, and infectious illnesses. Further, it engages in the investment, animal health and veterinary, pharmacy retail, and manpower supply and administration activities. The company was formerly known as Cadila Healthcare Limited and changed its name to Zydus Lifesciences Limited in February 2022. Zydus Lifesciences Limited was founded in 1952 and is headquartered in Ahmedabad, India. Zydus Lifesciences Limited is a subsidiary of Zydus Family Trust.
Compare ZYDU to Peers and Sector
Metrics to compare | ZYDU | Peers Peers - average of corresponding metrics from companies closely matching ZYDU: LUPIN, CIPLA, MOREPENLAB, ABBOTINDIA, GLENMARK | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipZYDUPeersSector |
|---|---|---|---|---|
P/E Ratio | 23.0x | 36.0x | −0.6x | |
PEG Ratio | 0.43 | 0.88 | 0.00 | |
Price/Book | 4.5x | 6.1x | 2.6x | |
Price / LTM Sales | 4.6x | 5.0x | 3.2x | |
Upside (Analyst Target) | 11.4% | 12.3% | 45.4% | |
Fair Value Upside | Unlock | −8.9% | 7.7% | Unlock |
Dividends
Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 42.65
Dividend Yield
0.31%
Industry Median 0.71%
Annualised payout
3
Paid annually
5-Years Growth
-
Growth Streak
People Also Watch
FAQ
What Is the Zydus Lifesciences (ZYDU) Stock Price Today?
The Zydus Lifesciences stock price today is 978.35
What Stock Exchange Does Zydus Lifesciences Trade On?
Zydus Lifesciences is listed and trades on the BSE stock exchange.
What Is the Stock Symbol for Zydus Lifesciences?
The stock symbol for Zydus Lifesciences is "ZYDU."
Does Zydus Lifesciences Pay Dividends? What’s The Current Dividend Yield?
The Zydus Lifesciences Ltd dividend yield is 0.31%.
What Is the Zydus Lifesciences Market Cap?
As of today, Zydus Lifesciences market cap is 983.85B.
What is Zydus Lifesciences Earnings Per Share?
The Zydus Lifesciences EPS is 42.65.
What Is the Next Zydus Lifesciences Earnings Date?
Zydus Lifesciences will release its next earnings report on 13 Feb 2025.
From a Technical Analysis Perspective, Is ZYDU a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.